Copyright
        ©The Author(s) 2021.
    
    
        World J Hepatol. Dec 27, 2021; 13(12): 2168-2178
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.2168
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.2168
            Table 1 Summary of the patient population
        
    | Overall (n = 23) | ||
| Age (median, IQR), n (%) | 60 | |
| Male | 14 | 60.9 | 
| Caucasian | 15 | 65% | 
| Etiology of cirrhosis | ||
| Alcohol (EtOH) | 3 | 13.0 | 
| Granulomatous hepatitis | 1 | 4.4 | 
| HBV | 1 | 4.4 | 
| HCV | 10 | 43.5 | 
| HCV, EtOH | 1 | 4.4 | 
| Nonalcoholic steatohepatitis | 6 | 26.1 | 
| Primary sclerosing cholangitis | 1 | 4.4 | 
| Liver biopsy | 10 | 43.5 | 
| Liver transplantation | 3 | 13.0 | 
| Portal hypertension on imaging | 17 | 73.9 | 
| TIPS | 2 | 8.7 | 
| Cirrhosis on CT/US | 23 | 100.0 | 
| History of connective tissue disease | 1 | 4.4 | 
| Dialysis | 2 | 8.7 | 
| Endoscopy suite, n (%) | ||
| Reason for EGD | ||
| Anemia | 1 | 4.4 | 
| GI Bleed | 4 | 17.4 | 
| Varices | 18 | 78.2 | 
| Anticoagulation | 0 | 0.0 | 
| Alcohol use in the past 15 d | 5 | 21.7 | 
| ASA in the past 15 d | 7 | 31.8 | 
| NSAIDS use in the past 15 d | 0 | 0.0 | 
| Plavix | 0 | 0.0 | 
| Beta blockers | 10 | 45.5 | 
| Labs within 3 mo Pre EGD1 | median | IQR | 
| Hemoglobin | 10.6 | 9.5–13.3 | 
| Mean corpuscular volume | 89.2 | 87.0–90.5 | 
| Platelet count | 126.5 | 68.0–152.0 | 
| INR | 1.1 | 1.1–1.2 | 
| Serum sodium | 139.0 | 137.0–142.0 | 
| Alanine aminotransferase | 30.0 | 25.0–54.0 | 
| Aspartate aminotransferase | 50.0 | 32.0–79.0 | 
| Total bilirubin | 1.6 | 1.2–2.6 | 
| Alkaline phosphatase | 108.0 | 85.0–134.0 | 
| Serum albumin | 3.2 | 2.4–3.4 | 
| Ferritin | 74.3 | 5.0–2458.0 | 
| Creatinine | 1.0 | 0.70–1.47 | 
| Labs within 4-8 wk after EGD1 | median | IQR | 
| Hemoglobin | 11.4 | 8.9–12.8 | 
| Mean corpuscular volume | 87.9 | 84.8–91.6 | 
| Platelet count | 117.0 | 63.0–166.0 | 
| INR | 1.2 | 1.1–1.3 | 
| Serum sodium | 140.0 | 137.0–142.0 | 
| Alanine aminotransferase | 31.0 | 21.0–42.0 | 
| Aspartate aminotransferase | 44.0 | 29.0–68.0 | 
| Total bilirubin | 1.2 | 0.9–1.9 | 
| Alkaline phosphatase | 132.0 | 79.0–185.0 | 
| Serum albumin | 3.0 | 2.6–3.3 | 
| Ferritin | 197.4 | 63.0–199.0 | 
| Creatinine | 1.0 | 0.70–1.50 | 
            Table 2 Comparison of white light and I-scan to the gold standard biopsy for diagnosis of gastric antral vascular ectasia
        
    | Biopsy | ||||
| No GAVE | GAVE | |||
| White Light | No GAVE | 10 | 1 | Sensitivity: 85.7% | 
| GAVE | 6 | 6 | Specificity: 62.5% | |
| I-Scan | No GAVE | 12 | 0 | Sensitivity: 100% | 
| GAVE | 4 | 7 | Specificity: 75.0% | |
            Table 3 Comparison of white light and I-scan to the gold standard biopsy for diagnosis of portal hypertensive gastropathy
        
    | Biopsy | ||||
| No PHG | PHG | |||
| White Light | No PHG | 4 | 1 | Sensitivity: 93.8% | 
| PHG | 3 | 15 | Specificity: 57.1% | |
| I-Scan | No PHG | 5 | 2 | Sensitivity: 87.5% | 
| PHG | 2 | 14 | Specificity: 71.4% | |
- Citation: Al-Taee AM, Cubillan MP, Hinton A, Sobotka LA, Befeler AS, Hachem CY, Hussan H. Accuracy of virtual chromoendoscopy in differentiating gastric antral vascular ectasia from portal hypertensive gastropathy: A proof of concept study. World J Hepatol 2021; 13(12): 2168-2178
- URL: https://www.wjgnet.com/1948-5182/full/v13/i12/2168.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i12.2168

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        